Urinary Catheters Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Intermittent Catheters, Foley/ Indwelling Catheters, External Catheters), By Application (Benign Prostate Hyperplasia & Prostate Surgeries, Urinary Incontinence, Spinal Cord Injury, Others), By Type (Coated Catheters, Uncoated Catheters), By End User (Hospital, Clinics, Long-Term Care Facilities, Others), By Region, & Competition, 2020-2030F

Market Overview

Global Urinary Catheters market was valued at USD 5.78 Billion in 2024 and is expected to reach USD 7.89 Billion by 2030 with a CAGR of 5.28%. The Global Urinary Catheters Market is undergoing consistent and sustainable growth, fueled by shifting demographics, a rising incidence of urological and chronic health conditions, technological advancements in catheter design, and the ongoing development of healthcare infrastructure across regions. Urinary catheters remain integral to the broader urology and chronic disease management landscape, providing critical solutions for both short-term and long-term bladder drainage and control.

The market is well-positioned for continued expansion, driven by an aging global population, increasing chronic disease prevalence, and a growing emphasis on personalized and home-based urological care. Industry stakeholders that focus on product innovation, infection prevention technologies, and wider accessibility will be strategically placed to capitalize on emerging opportunities and deliver sustained value in this evolving healthcare sector.

Key Market Drivers

Growing Prevalence of Urological Disorders and Chronic Diseases

The growing prevalence of urological disorders and chronic diseases is one of the most powerful and sustained drivers of growth in the Global Urinary Catheters Market. Urological disorders represent a major global public health challenge, impacting millions of individuals each year. Among these, urolithiasis (kidney stones) remains notably widespread, with an estimated 106 million new cases reported in 2021 reflecting a significant increase compared to incidence levels in 2000. This upward trend underscores the growing clinical and economic burden of kidney stone management on healthcare systems worldwide.  Medical conditions such as urinary incontinence, benign prostatic hyperplasia (BPH), neurogenic bladder, bladder obstruction, and post-surgical urinary retention are becoming increasingly common especially in aging populations and individuals with chronic comorbidities. Urinary incontinence is a widely recognized health issue among women, with prevalence rates reported to range between 8% and 45% across various clinical studies. This variability reflects both the widespread nature of the condition and the influence of demographic, lifestyle, and healthcare access factors, highlighting a substantial unmet need in female urological care globally. Benign prostatic hyperplasia (BPH), a non-malignant enlargement of the prostate, is a prevalent condition among men over the age of 60, impacting more than 50% of this demographic. As the prostate enlarges, it can constrict the urethra, resulting in bladder outlet obstruction and urinary retention conditions that often require long-term or intermittent catheterization for effective management. This drives consistent demand for urinary catheter solutions within the aging male population.

Non-urological chronic diseases are also contributing significantly to urinary complications that demand catheter-based solutions: Diabetes can cause autonomic neuropathy, leading to poor bladder emptying or urinary retention. Stroke and neurological disorders impair nerve signals that control bladder function, often resulting in loss of control or urinary retention. Cancer treatments, such as radiation therapy or pelvic surgeries, frequently result in temporary or long-term urinary complications that necessitate catheter use. As the global burden of chronic illness continues to grow, particularly in low- and middle-income countries, the demand for urological management tools including catheters is increasing proportionally. Patients with chronic diseases and urological conditions are more likely to undergo hospitalization, surgical procedures, or long-term care scenarios where urinary catheters are frequently used: Post-operative urinary retention (POUR) is a common complication following surgeries, particularly orthopedic, abdominal, or urological procedures. In intensive care units (ICUs), catheterization is often standard practice to manage urine output in critically ill patients with comorbid conditions. This direct link between chronic disease and hospital-based catheter use fuels steady demand from healthcare institutions, especially in aging societies.

As more patients with chronic diseases transition to home care or long-term care facilities, urinary catheters are increasingly used to manage bladder function outside hospital settings: Elderly and disabled patients with chronic mobility limitations often require indwelling or intermittent catheterization for daily bladder management. Care providers depend on catheter solutions to prevent complications such as skin breakdown, UTIs, or overdistention in patients with impaired bladder function. This shift is pushing the market toward recurring catheter sales, especially in regions where home healthcare infrastructure and reimbursement policies are well-established.

Rapidly Aging Global Population

The rapidly aging global population is one of the most influential long-term growth drivers for the Global Urinary Catheters Market, as it significantly increases the prevalence of age-related bladder dysfunction and dependency on long-term care. As populations around the world continue to live longer, age-associated health complications especially those impacting the urinary system are becoming more widespread and persistent, creating a robust and recurring demand for catheterization products. Older adults are more prone to urinary tract disorders, particularly urinary incontinence, benign prostatic hyperplasia (BPH), overactive bladder, and chronic urinary retention all of which often require catheter-based management. The incidence of Benign Prostatic Hyperplasia (BPH) rises sharply with age, affecting approximately 70% to 90% of men over the age of 80. This age-related enlargement of the prostate gland frequently results in bladder outlet obstruction, a common complication that often requires indwelling or intermittent catheterization for effective urinary management. The high prevalence of BPH in elderly male populations contributes significantly to sustained demand for catheter-based solutions in both clinical and long-term care settings. Women experience age-related weakening of the pelvic floor and bladder muscles, leading to a higher risk of urge and stress incontinence. Additionally, neurological decline due to aging (e.g., from dementia, Parkinson’s, or stroke) can impair the brain-bladder connection, leading to voiding dysfunction and the need for catheterization. This increased clinical burden among elderly patients drives a reliable, long-term demand for urinary catheters across hospitals, home care, and nursing facilities.

As populations age, there is a growing shift toward assisted living, nursing homes, and long-term care settings, where urinary catheters are routinely used for chronic bladder management and to ensure hygiene and patient comfort. Residents of long-term care facilities often have mobility impairments, cognitive decline, or advanced chronic diseases, making self-toileting difficult or impossible. Catheters play a vital role in maintaining dignity, skin integrity, and infection prevention for bedridden or immobile patients. Staff in eldercare settings increasingly depend on reliable, low-maintenance catheter solutions to improve operational efficiency and reduce complications. The growing global demand for eldercare services is creating a steady, institutional demand for urinary catheters especially Foley catheters and closed catheter systems.

Older patients undergo more frequent surgical procedures, including orthopedic, urological, and abdominal surgeries all of which can lead to post-operative urinary retention (POUR) or complications requiring catheterization. Elderly surgical patients are often catheterized before or after procedures to manage bladder function and monitor fluid output, particularly in high-risk or prolonged surgeries. Delayed voiding or urinary retention is a common post-operative issue in geriatric care, making short-term catheterization essential for recovery. A higher volume of surgical interventions in the aging population sustains hospital-based catheter usage, adding to the market’s clinical demand.

Download Free Sample Report

Key Market Challenges

High Risk of Catheter-Associated Urinary Tract Infections (CAUTIs)

One of the most significant clinical limitations impacting the urinary catheters market is the high incidence of catheter-associated urinary tract infections (CAUTIs), particularly with long-term indwelling catheter use.

CAUTIs account for a large proportion of hospital-acquired infections, leading to increased healthcare costs, prolonged hospital stays, and, in severe cases, life-threatening complications like sepsis. Despite innovations in antimicrobial coatings and hydrophilic designs, no solution has eliminated infection risks, leading clinicians to use catheters conservatively and only when necessary. Regulatory bodies and hospital systems are enforcing stricter infection prevention guidelines, which can reduce routine catheter use and slow demand growth.

This clinical drawback has led to increased scrutiny around catheter utilization, especially in inpatient settings, and discourages unnecessary or prolonged use, ultimately restricting overall market potential.

Limited Awareness and Access in Emerging Markets

Although urinary catheters are widely used in developed regions, accessibility and awareness remain limited in low- and middle-income countries, where healthcare infrastructure is often underdeveloped.

A large portion of the population in these markets may lack diagnosis and treatment for urological disorders, meaning they go untreated or are managed suboptimally. Shortages of trained medical personnel, inadequate reimbursement frameworks, and limited availability of specialized catheter types (e.g., hydrophilic, compact, or pediatric models) further hinder market penetration. Additionally, in many rural areas, cultural stigma and limited patient education about catheterization methods (especially self-catheterization) act as significant barriers to adoption.

Despite the high potential demand due to demographic trends, emerging markets remain underpenetrated, delaying revenue realization and limiting global growth momentum.

Key Market Trends

Technological Advancements in Catheter Design and Materials

A wave of innovation is redefining the urinary catheter landscape, moving beyond traditional product designs toward safer, more comfortable, and infection-resistant solutions. Hydrophilic-coated and pre-lubricated catheters, which reduce friction and lower the risk of urethral trauma and urinary tract infections (UTIs). Antimicrobial and silicone-based catheters, designed to prevent biofilm formation and resist encrustation two major causes of catheter-related complications. Safety-enhanced designs, such as InnoCare Urologics’ FDA-cleared Egress™ catheter, which features an automatic balloon deflation mechanism to prevent traumatic injuries during accidental removal.

These innovations are not only improving clinical outcomes but also enhancing patient experience, compliance, and physician confidence, thereby accelerating adoption across both institutional and home-care settings.

Rising Preference for Home Healthcare and Self-Catheterization

There is a clear global shift toward decentralized, patient-managed care, driven by aging populations, rising chronic disease incidence, and pressure to reduce hospital burden. As a result, intermittent self-catheterization (ISC) is gaining prominence.

Patients with neurogenic bladder, spinal cord injuries, or post-surgical recovery are increasingly opting for intermittent catheters due to their portability, ease of use, and lower infection risk compared to indwelling options. Medical device companies are developing compact, discreet, and ergonomically designed catheters, making them more practical for everyday use without clinical supervision. Governments and healthcare systems are investing in training programs and digital platforms to support patient education on catheterization techniques at home.

This trend is expected to be a major growth engine for the market, especially in developed regions with robust home healthcare infrastructure and favorable reimbursement models.

Segmental Insights

Product Insights

Based on the category of Product, the Intermittent Catheters segment emerged as the fastest growing in the market for Urinary Catheters in 2024. Intermittent catheters are particularly well-suited for self-catheterization, empowering patients especially those with spinal cord injuries, multiple sclerosis, or neurogenic bladder to manage their condition independently. This aligns with the global trend toward home-based care and patient autonomy, leading to a surge in demand for user-friendly, disposable intermittent catheters. Moreover, increased awareness and training programs around self-catheterization are expanding the user base, especially in developed regions like North America and Europe.

Healthcare systems and insurance providers across developed markets are incentivizing intermittent catheter use due to their lower long-term costs and reduced complication rates. For instance, favorable reimbursement policies in the U.S. under Medicare and private insurers encourage physicians and patients to opt for intermittent catheterization, further boosting market penetration. These factors contribute to the growth of this segment.

Application Insights

Based on the category of Application, the Urinary Incontinence segment emerged as the dominating segment in the market for Urinary Catheters in 2024. Urinary incontinence particularly stress, urge, and overflow incontinence affect a significant portion of the global population, especially elderly individuals, women post-childbirth, and patients with neurological disorders. According to the World Health Organization and various urological health bodies, hundreds of millions of people globally suffer from some form of UI. This widespread prevalence translates into sustained and growing demand for urinary catheterization as a key management strategy, especially when conservative therapies fail.

The incidence of urinary incontinence is strongly correlated with age, and with populations in North America, Europe, and parts of Asia aging rapidly, there is a corresponding rise in UI cases. Moreover, conditions like diabetes, obesity, Parkinson’s disease, and multiple sclerosis which can impair bladder control are becoming more common worldwide. This trend has significantly expanded the patient base reliant on intermittent and indwelling catheter solutions for UI management.

Download Free Sample Report

Regional Insights

North America emerged as the largest market in the global Urinary Catheters market in 2024, holding the largest market share in terms of value. North America, particularly the United States and Canada, has a rapidly aging population, which is more susceptible to conditions such as urinary incontinence, benign prostatic hyperplasia (BPH), neurogenic bladder, and other chronic urological disorders. According to the U.S. CDC and National Association for Continence, millions of Americans experience urinary incontinence fueling sustained demand for long-term catheter use in both home care and institutional settings.

The region boasts a well-established healthcare infrastructure, characterized by a high density of hospitals, ambulatory surgical centers, long-term care facilities, and specialty urology clinics. Additionally, greater access to reimbursement mechanisms, including Medicare and private insurance coverage, reduces out-of-pocket costs for patients, thus supporting higher product uptake across diverse patient demographics. North America is home to leading medical device companies and R&D hubs. The U.S. FDA’s well-defined regulatory framework and support for innovation such as 510(k) clearances for advanced catheter technologies (e.g., safety catheters, antimicrobial coatings, catheter-free diagnostic systems) has fostered a competitive landscape rich in product differentiation and clinical efficacy.

Recent Developments

• In April 2025, Bright Uro, a medical device innovator focused on redefining diagnostics for lower urinary tract dysfunction (LUTD), has received FDA 510(k) clearance for its Glean™ Urodynamics System a first-of-its-kind, wireless and catheter-free platform designed for real-world, ambulatory urodynamic monitoring. This system represents a significant shift from conventional, catheter-dependent diagnostic methods by allowing clinicians to collect comprehensive bladder function data in natural, daily-life settings, thereby improving diagnostic accuracy and patient comfort.
• In January 2025, Sanford Health’s radiologist Dr. Bruce Gardner has introduced a groundbreaking Foley catheter designed to significantly enhance patient safety. Developed and manufactured in partnership with InnoCare Urologics, the Egress™ Foley catheter incorporates an innovative internal release mechanism: when the catheter is inadvertently pulled while the retention balloon is still inflated, a metal filament triggers automatic balloon deflation, preventing serious urethral injury.
• In December 2024- InnoCare Urologics has officially secured FDA 510(k) clearance for its proprietary Egress safety catheter, marking a significant regulatory and clinical milestone in urinary care innovation. Unlike traditional indwelling catheters, which pose a high risk of severe urethral trauma if forcibly removed while the retention balloon is still inflated, the Egress catheter integrates a patented safety mechanism that automatically deflates the balloon in response to traction forces, thereby proactively preventing injury.
• In January 2024, Supported by artificial intelligence, a novel catheter design has been developed to effectively mitigate the risk of bacterial infections a persistent challenge in clinical environments. Leveraging AI-driven bioengineering, this innovation specifically addresses the high incidence of catheter-associated infections caused by motile bacteria, which are adept at navigating through urinary catheters and establishing colonies. By targeting the root of bacterial ingress and colonization, the new design offers a targeted, preventative solution poised to reduce infection-related complications and associated healthcare costs.

Key Market Players

• Hollister Incorporated
• Medtronic PLC
• Boston Scientific Corporation
• BD
• Cook Medical
• Convatec Inc
• Teleflex Incorporated
• Coloplast Corp
• B. Braun SE
• Medline Industries, LP

Report Scope:

In this report, the Global Urinary Catheters Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Urinary Catheters Market, By Product:

o   Intermittent Catheters

o   Foley/ Indwelling Catheters

o   External Catheters

• Urinary Catheters Market, By Application:

o   Benign Prostate Hyperplasia & Prostate Surgeries

o   Urinary Incontinence

o   Spinal Cord Injury

o   Others

• Urinary Catheters Market, By Type:

o   Coated Catheters

o   Uncoated Catheters

• Urinary Catheters Market, By End User:

o   Hospital

o   Clinics

o   Long-Term Care Facilities

o   Others

• Urinary Catheters Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Urinary Catheters Market.

Available Customizations:

Global Urinary Catheters market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).